Antibody gene therapy: an attractive approach for the treatment of cancers and other chronic diseases.
Zheng
Dexian
D
National Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100005, China. zhengdx@pumc.edu.cn
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D017209:Apoptosis; D001343:Autophagy; D020169:Caspases / Q000378:metabolism; D045744:Cell Line, Tumor; D002908:Chronic Disease; D000229:Dependovirus / Q000235:genetics*; D004789:Enzyme Activation; D015316:Genetic Therapy; D005822:Genetic Vectors; D006801:Humans; D007135:Immunoglobulin Variable Region / Q000276:immunology*; D051379:Mice; D016328:NF-kappa B / Q000378:metabolism; D009369:Neoplasms / Q000188:drug therapy* / Q000276:immunology; D053220:Receptors, TNF-Related Apoptosis-Inducing Ligand / Q000276:immunology* / Q000378:metabolism; D015398:Signal Transduction; D053221:TNF-Related Apoptosis-Inducing Ligand / Q000378:metabolism; D014183:Transplantation, Heterologous
D000911:Antibodies, Monoclonal; D007135:Immunoglobulin Variable Region; D016328:NF-kappa B; D053220:Receptors, TNF-Related Apoptosis-Inducing Ligand; D053221:TNF-Related Apoptosis-Inducing Ligand; D020169:Caspases